ARS Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
ARS Pharmaceuticals, Inc. has filed 523 SEC EDGAR filings since 12 Apr 2016

SEC filing history

Showing 226-250 of 523 matching filings.

Per page
25
Current page
10
ARS File 001-39756

ARS

Filing date
26 Apr 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-39756

DEFA14A

Filing date
26 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39756

DEF 14A

Filing date
26 Apr 2024
Reporting date
20 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Apr 2024
Reporting date
23 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
24 Apr 2024
Reporting date
23 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Apr 2024
Reporting date
19 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Apr 2024
Reporting date
19 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
17 Apr 2024
Reporting date
16 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
09 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Apr 2024
Reporting date
09 Apr 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-91894

SC 13D/A

Filing date
29 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
27 Mar 2024
Reporting date
25 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Mar 2024
Reporting date
22 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Mar 2024
Reporting date
22 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Mar 2024
Reporting date
19 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
21 Mar 2024
Reporting date
19 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-278150

S-8

Filing date
21 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
15 Mar 2024
Reporting date
13 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
01 Mar 2024
Reporting date
29 Feb 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .